INS and metabolic dysfunction-associated steatotic liver disease: It is well established that patients with NAFLD due to the genetic risk variants in PNPLA335, TM6SF236 and MBOAT713 are at risk of fibrosis but these patients are neither more obese nor insulin resistant compared to non-carriers of the variants37–39.